CLINICAL_TRIALS
trial_result
· 2017-08-09
Clinical Trial Update: Glutamine for the Treatment of Patients With Irritable Bowel Syndrome [Phase 2]
Summary
Phase 2 trial of glutamine for diarrhea-predominant irritable bowel syndrome has completed. Results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tulane University | Conditions: Diarrhea-Predominant Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-08-09